$173.56
+141.67 (+444.23%)
1Y
About
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and ...
HQ: South San Francisco, CA · Founded: 2013 · Employees: 979 · CEO: Emily Marine Leproust ·Revenue (TTM): $432M
www.twistbioscience.com Company Info
Sector
Health Care Industry
Biotechnology Country
United States Exchange
NASDAQ Currency
USD Financial Metrics
Day Range
$170.22 $219.71
52-Week Range
$23.30 $219.71
Prev Close
$205.00 Market Cap
$10.4B P/E Ratio
— Forward P/E
— EPS (TTM)
$-2.23 Profit Margin
-31.7% Div Yield
— Annual Dividend
— Avg Volume
2M Beta
1.33 Track TWST in your portfolio
See how Twist Bioscience Corporation affects your portfolio risk, drawdown, and diversification.
Get started